MarketCapTrends
LXRX
Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ · Healthcare

Lexicon Pharmaceuticals, Inc. Total Liabilities 2009–2025

Lexicon Pharmaceuticals, Inc. annual/quarterly total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Lexicon Pharmaceuticals, Inc. total liabilities for the quarter ending December 31, 2025 were 77.4M, a 49.20% decrease year-over-year.
  • Lexicon Pharmaceuticals, Inc. total liabilities for 2025 were 77.4M, a 49.20% decrease from 2024.
  • Lexicon Pharmaceuticals, Inc. total liabilities for 2024 were 152.5M, a 11.85% increase from 2023.
  • Lexicon Pharmaceuticals, Inc. total liabilities for 2023 were 136.3M, a 76.64% increase from 2022.
  • Lexicon Pharmaceuticals, Inc. total liabilities for 2022 were 77.2M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Lexicon Pharmaceuticals, Inc. Annual Total Liabilities (Millions of US $)
2025$77
2024$152
2023$136
2022$77
2021$23
2020$47
2019$301
2018$311
2017$368
2016$318
2015$366
2014$187
2013$104
2012$105
2011$133
Lexicon Pharmaceuticals, Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$77
2024-12-31$152
2023-12-31$136
2022-12-31$77
2021-12-31$23
2020-12-31$47
2019-12-31$301
2018-12-31$311
2017-12-31$368
2016-12-31$318
2015-12-31$366
2014-12-31$187
2013-12-31$104
2012-12-31$105
2011-12-31$133
2010-12-31$120

Lexicon Pharmaceuticals, Inc. Total Liabilities — FAQ

Lexicon Pharmaceuticals, Inc. (LXRX) total liabilities over the last 17 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see LXRX's total liabilities history?

The chart and table above show Lexicon Pharmaceuticals, Inc.'s total liabilities by year and by quarter, including the growth rate.